Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registry.

Puymirat E, Didier R, Eltchaninoff H, Lung B, Collet JP, Himbert D, Durand E, Leguerrier A, Leprince P, Fajadet J, Teiger E, Chevreul K, Lièvre M, Tchetché D, Leclercq F, Chassaing S, Le Breton H, Donzeau-Gouge P, Lefèvre T, Carrié D, Gillard M, Blanchard D.

Clin Cardiol. 2017 Dec;40(12):1316-1322. doi: 10.1002/clc.22830. Epub 2017 Dec 16.

2.

Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial.

Courand PY, Pereira H, Del Giudice C, Gosse P, Monge M, Bobrie G, Delsart P, Mounier-Vehier C, Lantelme P, Denolle T, Dourmap C, Halimi JM, Girerd X, Rossignol P, Zannad F, Ormezzano O, Vaisse B, Herpin D, Ribstein J, Bouhanick B, Mourad JJ, Ferrari E, Chatellier G, Sapoval M, Azarine A, Azizi M; DENERHTN Investigators.

J Am Heart Assoc. 2017 Oct 10;6(10). pii: e007062. doi: 10.1161/JAHA.117.007062.

3.

Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.

Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, Béjot Y, Vuillier F, Detante O, Guidoux C, Canaple S, Vaduva C, Dequatre-Ponchelle N, Sibon I, Garnier P, Ferrier A, Timsit S, Robinet-Borgomano E, Sablot D, Lacour JC, Zuber M, Favrole P, Pinel JF, Apoil M, Reiner P, Lefebvre C, Guérin P, Piot C, Rossi R, Dubois-Randé JL, Eicher JC, Meneveau N, Lusson JR, Bertrand B, Schleich JM, Godart F, Thambo JB, Leborgne L, Michel P, Pierard L, Turc G, Barthelet M, Charles-Nelson A, Weimar C, Moulin T, Juliard JM, Chatellier G; CLOSE Investigators.

N Engl J Med. 2017 Sep 14;377(11):1011-1021. doi: 10.1056/NEJMoa1705915.

PMID:
28902593
4.

Baseline characteristics and outcomes after transcatheter aortic-valve implantation in patients with or without previous balloon aortic valvuloplasty: Insights from the FRANCE 2 registry.

Bière L, Durfort A, Fouquet O, Hamel JF, Leprince P, Chevreul K, Prat A, Lievre M, Donzeau-Gouge P, Fajadet J, Teiger E, Eltchaninoff H, Iung B, Leguerrier A, Gilard M, Furber A.

Arch Cardiovasc Dis. 2017 Oct;110(10):534-542. doi: 10.1016/j.acvd.2016.12.012. Epub 2017 May 3.

PMID:
28479042
5.

Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry.

Gilard M, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Tchetche D, Carrié D, Himbert D, Albat B, Cribier A, Sudre A, Blanchard D, Rioufol G, Collet F, Houel R, Dos Santos P, Meneveau N, Ghostine S, Manigold T, Guyon P, Grisoli D, Le Breton H, Delpine S, Didier R, Favereau X, Souteyrand G, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Laskar M, Iung B; FRANCE 2 Investigators.

J Am Coll Cardiol. 2016 Oct 11;68(15):1637-1647. doi: 10.1016/j.jacc.2016.07.747.

6.

Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.

Azizi M, Pereira H, Hamdidouche I, Gosse P, Monge M, Bobrie G, Delsart P, Mounier-Véhier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Girerd X, Michel Halimi J, Zannad F, Ormezzano O, Vaïsse B, Herpin D, Ribstein J, Chamontin B, Mourad JJ, Ferrari E, Plouin PF, Jullien V, Sapoval M, Chatellier G; DENERHTN Investigators.

Circulation. 2016 Sep 20;134(12):847-57. doi: 10.1161/CIRCULATIONAHA.116.022922. Epub 2016 Aug 30.

7.

close: Closure of patent foramen ovale, oral anticoagulants or antiplatelet therapy to prevent stroke recurrence: Study design.

Mas JL, Derumeaux G, Amarenco P, Arquizan C, Aubry P, Barthelet M, Bertrand B, Brochet E, Cabanes L, Donal E, Dubois-Randé JL, Durand-Zaleski I, Ernande L, Finet G, Fraisse A, Giroud M, Guérin P, Habib G, Juliard JM, Leys D, Lièvre M, Lusson JR, Marcon F, Michel P, Moulin T, Mounier-Vehier F, Pierard L, Piot C, Rey C, Rodier G, Roudaut R, Schleich JM, Teiger E, Turc G, Vuillier F, Weimar C, Woimant F, Chatellier G; CLOSE investigators.

Int J Stroke. 2016 Aug;11(6):724-32. doi: 10.1177/1747493016643551. Epub 2016 Apr 7.

PMID:
27056964
8.

Identifying developmental phases in the Arabidopsis thaliana rosette using integrative segmentation models.

Lièvre M, Granier C, Guédon Y.

New Phytol. 2016 Jun;210(4):1466-78. doi: 10.1111/nph.13861. Epub 2016 Feb 8.

9.

Management of adolescents with very poorly controlled type 1 diabetes by nurses: a parallel group randomized controlled trial.

Kassai B, Rabilloud M, Bernoux D, Michal C, Riche B, Ginhoux T, Laudy V, Terral D, Didier-Wright C, Maire V, Dumont C, Cottancin G, Plasse M, Jeannoel GP, Khoury J, Bony C, Lièvre M, Drai J, Nicolino M.

Trials. 2015 Sep 8;16:399. doi: 10.1186/s13063-015-0923-7.

10.

Baseline Characteristics and Prognostic Implications of Pre-Existing and New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation: Results From the FRANCE-2 Registry.

Chopard R, Teiger E, Meneveau N, Chocron S, Gilard M, Laskar M, Eltchaninoff H, Iung B, Leprince P, Chevreul K, Prat A, Lievre M, Leguerrier A, Donzeau-Gouge P, Fajadet J, Mouillet G, Schiele F; FRANCE-2 Investigators.

JACC Cardiovasc Interv. 2015 Aug 24;8(10):1346-55. doi: 10.1016/j.jcin.2015.06.010.

11.

Comparison of Outcome of Transcatheter Aortic Valve Implantation With Versus Without Previous Coronary Artery Bypass Grafting (from the FRANCE 2 Registry).

Castellant P, Didier R, Bezon E, Couturaud F, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Laskar M, Boschat J, Gilard M; FRANCE 2 Investigators.

Am J Cardiol. 2015 Aug 1;116(3):420-5. doi: 10.1016/j.amjcard.2015.04.057. Epub 2015 May 9.

PMID:
26071993
12.

Comparison of outcomes after one-versus-two transcatheter aortic valve implantation during a same procedure (from the FRANCE2 Registry).

Clerfond G, Pereira B, Innorta A, Motreff P, Gilard M, Laskar M, Eltchaninoff H, Iung B, Leprince P, Teiger E, Chevreul K, Prat A, Lievre M, Leguerrier A, Donzeau-Gouge P, Fajadet J, Souteyrand G.

Am J Cardiol. 2015 May 1;115(9):1273-80. doi: 10.1016/j.amjcard.2015.01.560. Epub 2015 Feb 12.

PMID:
25791239
13.

Impact of pre- and post-procedural anemia on the incidence of acute kidney injury and 1-year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry).

Arai T, Morice MC, O'Connor SA, Yamamoto M, Eltchaninoff H, Leguerrier A, Leprince P, Laskar M, Iung B, Fajadet J, Prat A, Lièvre M, Donzeau-Gouge P, Chevreul K, Teiger E, Lefèvre T, Gilard M; FRANCE 2 Registry Investigators.

Catheter Cardiovasc Interv. 2015 Jun;85(7):1231-9. doi: 10.1002/ccd.25832. Epub 2015 Feb 3.

PMID:
25641110
14.

Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial.

Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, Midulla M, Mounier-Véhier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Trillaud H, Pereira H, Plouin PF, Chatellier G; Renal Denervation for Hypertension (DENERHTN) investigators.

Lancet. 2015 May 16;385(9981):1957-65. doi: 10.1016/S0140-6736(14)61942-5. Epub 2015 Jan 26.

PMID:
25631070
15.

Impact of chronic kidney disease on the outcomes of transcatheter aortic valve implantation: results from the FRANCE 2 registry.

Oguri A, Yamamoto M, Mouillet G, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande JL, Teiger E; FRANCE 2 Registry investigators.

EuroIntervention. 2015 Jan;10(9):e1-9. doi: 10.4244/EIJV10I9A183.

16.

Response to letter regarding article, "postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 registry".

Van Belle E, Juthier F, Susen S, Vincentelli A, Dallongeville J, Iung B, Eltchaninoff H, Laskar M, Leprince P, Lievre M, Banfi C, Auffray JL, Delhaye C, Donzeau-Gouge P, Chevreul K, Fajadet J, Leguerrier A, Prat A, Gilard M, Teiger E; FRANCE 2 Investigators.

Circulation. 2015 Jan 13;131(2):e16-7. doi: 10.1161/CIRCULATIONAHA.114.012815. No abstract available.

17.

Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis.

Sundström J, Arima H, Jackson R, Turnbull F, Rahimi K, Chalmers J, Woodward M, Neal B; Blood Pressure Lowering Treatment Trialists' Collaboration.

Ann Intern Med. 2015 Feb 3;162(3):184-91. doi: 10.7326/M14-0773. Review.

PMID:
25531552
18.

Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials.

Blood Pressure Lowering Treatment Trialists' Collaboration, Ying A, Arima H, Czernichow S, Woodward M, Huxley R, Turnbull F, Perkovic V, Neal B.

Lancet. 2015 Mar 7;385(9971):867-74. doi: 10.1016/S0140-6736(14)61171-5. Epub 2014 Nov 4.

PMID:
25468168
19.

Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.

Cariou B, Fontaine P, Eschwege E, Lièvre M, Gouet D, Huet D, Madani S, Lavigne S, Charbonnel B.

Diabetes Metab. 2015 Apr;41(2):116-25. doi: 10.1016/j.diabet.2014.10.007. Epub 2014 Nov 24.

PMID:
25465273
20.

Impact of low preprocedural transvalvular gradient on cardiovascular mortality following TAVI: an analysis from the FRANCE 2 registry.

Amabile N, Agostini H, Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Laskar M, Caussin C.

EuroIntervention. 2014 Nov;10(7):842-9. doi: 10.4244/EIJV10I7A144.

Supplemental Content

Loading ...
Support Center